| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An unmet need for long-term follow-up in Hodgkin's lymphoma?
|
Gisselbrecht, Christian
|
|
2018
|
5 |
10 |
p. e435-e436
|
artikel
|
| 2 |
Beta-thalassaemia: all roads lead to a cure?
|
The Lancet Haematology,
|
|
2018
|
5 |
10 |
p. e430
|
artikel
|
| 3 |
Brentuximab vedotin for lymphoma in paediatric patients
|
Sureda, Anna
|
|
2018
|
5 |
10 |
p. e433-e434
|
artikel
|
| 4 |
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
|
Locatelli, Franco
|
|
2018
|
5 |
10 |
p. e450-e461
|
artikel
|
| 5 |
Immunoglobulin therapy and passive transfer of anti-HBc: too often forgotten
|
Hui, Edwin Pun
|
|
2018
|
5 |
10 |
p. e437-e438
|
artikel
|
| 6 |
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials
|
von Tresckow, Bastian
|
|
2018
|
5 |
10 |
p. e462-e473
|
artikel
|
| 7 |
Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review
|
Lu, Huifang
|
|
2018
|
5 |
10 |
p. e474-e478
|
artikel
|
| 8 |
Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study
|
Søgaard, Kirstine Kobberøe
|
|
2018
|
5 |
10 |
p. e441-e449
|
artikel
|
| 9 |
Splanchnic vein thrombosis: what are the long-term risks?
|
Schulman, Sam
|
|
2018
|
5 |
10 |
p. e431-e432
|
artikel
|
| 10 |
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial
|
van de Donk, Niels WCJ
|
|
2018
|
5 |
10 |
p. e479-e492
|
artikel
|
| 11 |
Thalidomide for myeloma: still here?
|
Dimopoulos, Meletios A
|
|
2018
|
5 |
10 |
p. e439-e440
|
artikel
|
Tijdschrift beschrijving